Mohamed Elsayed

600 total citations
19 papers, 421 citations indexed

About

Mohamed Elsayed is a scholar working on Organic Chemistry, Molecular Biology and Toxicology. According to data from OpenAlex, Mohamed Elsayed has authored 19 papers receiving a total of 421 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Organic Chemistry, 11 papers in Molecular Biology and 6 papers in Toxicology. Recurrent topics in Mohamed Elsayed's work include Cancer therapeutics and mechanisms (7 papers), Bioactive Compounds and Antitumor Agents (6 papers) and Synthesis and biological activity (6 papers). Mohamed Elsayed is often cited by papers focused on Cancer therapeutics and mechanisms (7 papers), Bioactive Compounds and Antitumor Agents (6 papers) and Synthesis and biological activity (6 papers). Mohamed Elsayed collaborates with scholars based in United States, Egypt and Germany. Mohamed Elsayed's co-authors include Mark Cushman, Keli Agama, Yves Pommier, Nanjie Deng, Danzhou Yang, Guanhui Wu, Kai‐Bo Wang, Christophe Marchand, Michael Linscheid and Peng‐Cheng Lv and has published in prestigious journals such as Journal of the American Chemical Society, PLoS ONE and Cancer Research.

In The Last Decade

Mohamed Elsayed

18 papers receiving 419 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mohamed Elsayed United States 11 216 215 57 40 29 19 421
Petra Grbčić Croatia 13 239 1.1× 206 1.0× 44 0.8× 74 1.9× 14 0.5× 26 496
Yong‐Cheng Ma China 13 344 1.6× 275 1.3× 53 0.9× 42 1.1× 43 1.5× 19 630
A. S. Prakasha Gowda United States 12 154 0.7× 251 1.2× 46 0.8× 18 0.5× 24 0.8× 23 408
Lalita Guntuku India 12 315 1.5× 166 0.8× 36 0.6× 15 0.4× 28 1.0× 13 480
Peter T. Rye United States 10 105 0.5× 152 0.7× 66 1.2× 29 0.7× 16 0.6× 11 326
Nazlıhan Aztopal Türkiye 11 125 0.6× 205 1.0× 161 2.8× 22 0.6× 24 0.8× 22 415
Manav Malhotra India 13 305 1.4× 135 0.6× 56 1.0× 29 0.7× 15 0.5× 38 473
Filippo Prencipe Italy 15 396 1.8× 164 0.8× 71 1.2× 13 0.3× 29 1.0× 28 544
Yulia L. Volodina Russia 12 120 0.6× 170 0.8× 38 0.7× 24 0.6× 71 2.4× 25 308
Yinglin Zuo China 11 160 0.7× 254 1.2× 62 1.1× 16 0.4× 16 0.6× 18 436

Countries citing papers authored by Mohamed Elsayed

Since Specialization
Citations

This map shows the geographic impact of Mohamed Elsayed's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mohamed Elsayed with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mohamed Elsayed more than expected).

Fields of papers citing papers by Mohamed Elsayed

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mohamed Elsayed. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mohamed Elsayed. The network helps show where Mohamed Elsayed may publish in the future.

Co-authorship network of co-authors of Mohamed Elsayed

This figure shows the co-authorship network connecting the top 25 collaborators of Mohamed Elsayed. A scholar is included among the top collaborators of Mohamed Elsayed based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mohamed Elsayed. Mohamed Elsayed is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Yang, Danzhou, et al.. (2023). Abstract 3103: Dual targeting MYC G-quadruplex and topoisomerase I by indenoisoquinolines for cancer therapy. Cancer Research. 83(7_Supplement). 3103–3103.
2.
Mohammed, A. B. Abeer, Amr M. Mohamed, Noura El‐Ahmady El‐Naggar, et al.. (2022). Antioxidant and Antibacterial Activities of Silver Nanoparticles Biosynthesized by Moringa oleifera through Response Surface Methodology. Journal of Nanomaterials. 2022(1). 40 indexed citations
3.
Wang, Kai‐Bo, Mohamed Elsayed, Guanhui Wu, et al.. (2019). Indenoisoquinoline Topoisomerase Inhibitors Strongly Bind and Stabilize the MYC Promoter G-Quadruplex and Downregulate MYC. Journal of the American Chemical Society. 141(28). 11059–11070. 80 indexed citations
4.
Marzi, Laetitia, Keli Agama, Junko Murai, et al.. (2018). Novel Fluoroindenoisoquinoline Non-Camptothecin Topoisomerase I Inhibitors. Molecular Cancer Therapeutics. 17(8). 1694–1704. 32 indexed citations
5.
6.
Elsayed, Mohamed, Sungtae Park, Jeongho Park, et al.. (2018). Application of Sequential Palladium Catalysis for the Discovery of Janus Kinase Inhibitors in the Benzo[c]pyrrolo[2,3-h][1,6]naphthyridin-5-one (BPN) Series. Journal of Medicinal Chemistry. 61(23). 10440–10462. 15 indexed citations
7.
Elsayed, Mohamed, et al.. (2018). Synthesis of Benzo[1,6]naphthyridinones Using the Catellani Reaction. Organic Letters. 20(17). 5228–5232. 25 indexed citations
8.
Elsayed, Mohamed, et al.. (2018). Exploring Identifiers of Research Articles Related to Food and Disease using Artificial Intelligence. International Journal of Advanced Computer Science and Applications. 9(11). 1 indexed citations
9.
El-morsy, Ahmed, Mohamed Elsayed, & Hamada S. Abulkhair. (2017). Synthesis, Characterization and <i>In Vitro</i> Antitumor Evaluation of New Pyrazolo[3,4-d]Pyrimidine Derivatives. 7(1). 1–17. 12 indexed citations
10.
Elsayed, Mohamed, et al.. (2017). Ligand-free, palladacycle-facilitated Suzuki coupling of hindered 2-arylbenzothiazole derivatives yields potent and selective COX-2 inhibitors. Organic & Biomolecular Chemistry. 16(1). 108–118. 9 indexed citations
11.
Wang, Ping, Mohamed Elsayed, Christophe E. Redon, et al.. (2017). Synthesis and Biological Evaluation of the First Triple Inhibitors of Human Topoisomerase 1, Tyrosyl–DNA Phosphodiesterase 1 (Tdp1), and Tyrosyl–DNA Phosphodiesterase 2 (Tdp2). Journal of Medicinal Chemistry. 60(8). 3275–3288. 45 indexed citations
12.
Elsayed, Mohamed, Ping Wang, Keli Agama, et al.. (2017). Design and Synthesis of Chlorinated and Fluorinated 7-Azaindenoisoquinolines as Potent Cytotoxic Anticancer Agents That Inhibit Topoisomerase I. Journal of Medicinal Chemistry. 60(13). 5364–5376. 32 indexed citations
13.
Elsayed, Mohamed, Mat­thias Zeller, & Mark Cushman. (2016). Synthesis of indolo[4,3-bc]phenanthridine-6,11(2H,12H)-diones using the schiff base–homophthalic anhydride cyclization reaction. Synthetic Communications. 46(23). 1902–1908. 6 indexed citations
14.
Lv, Peng‐Cheng, Mohamed Elsayed, Keli Agama, et al.. (2016). Design, Synthesis, and Biological Evaluation of Potential Prodrugs Related to the Experimental Anticancer Agent Indotecan (LMP400). Journal of Medicinal Chemistry. 59(10). 4890–4899. 45 indexed citations
15.
Elsayed, Mohamed. (2014). Real Time and Conventional PCR for Characterization of Salmonella sp. from Imported Meat to Egypt. Advances in Animal and Veterinary Sciences. 2(4). 199–203. 5 indexed citations
16.
Elsayed, Mohamed, Moustafa E. El‐Araby, Rabah A.T. Serya, et al.. (2012). Structure-based design and synthesis of novel pseudosaccharine derivatives as antiproliferative agents and kinase inhibitors. European Journal of Medicinal Chemistry. 61. 122–131. 41 indexed citations
17.
18.
Elsayed, Mohamed, Moustafa E. El‐Araby, Rabah A.T. Serya, & Khaled A. M. Abouzid. (2012). Virtual Screening and Synthesis of New Chemical Scaffolds as VEGFR-2 Kinase Inhibitors. Arzneimittelforschung. 62(12). 554–560. 1 indexed citations
19.
Mahmoud, Amr H., Mohamed Elsayed, & Mahmoud ElHefnawi. (2012). Structure-based predictive model for some benzimidazole inhibitors of hepatitis C virus NS5B polymerase. Medicinal Chemistry Research. 22(4). 1866–1883. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Petra Grbčić Breakdown of academic impact, for papers by Yong‐Cheng Ma Breakdown of academic impact, for papers by A. S. Prakasha Gowda Breakdown of academic impact, for papers by Lalita Guntuku Breakdown of academic impact, for papers by Peter T. Rye Breakdown of academic impact, for papers by Nazlıhan Aztopal Breakdown of academic impact, for papers by Manav Malhotra Breakdown of academic impact, for papers by Filippo Prencipe Breakdown of academic impact, for papers by Yulia L. Volodina Breakdown of academic impact, for papers by Yinglin Zuo
Rankless by CCL
2026